SQUARCIALUPI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 2.398
EU - Europa 1.417
AS - Asia 1.043
SA - Sud America 140
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 20
Totale 5.085
Nazione #
US - Stati Uniti d'America 2.357
RU - Federazione Russa 451
IT - Italia 301
CN - Cina 247
VN - Vietnam 246
SG - Singapore 231
IE - Irlanda 198
HK - Hong Kong 125
SE - Svezia 118
BR - Brasile 113
PL - Polonia 112
KR - Corea 63
DE - Germania 61
FI - Finlandia 55
FR - Francia 50
IN - India 43
GB - Regno Unito 35
CA - Canada 27
JP - Giappone 22
AU - Australia 20
JO - Giordania 14
AR - Argentina 12
MA - Marocco 9
MX - Messico 9
TR - Turchia 9
BD - Bangladesh 8
CI - Costa d'Avorio 8
ID - Indonesia 8
ES - Italia 7
NL - Olanda 7
PK - Pakistan 6
UA - Ucraina 6
ZA - Sudafrica 6
EC - Ecuador 5
IQ - Iraq 5
EE - Estonia 4
AZ - Azerbaigian 3
CH - Svizzera 3
BE - Belgio 2
BO - Bolivia 2
CO - Colombia 2
EG - Egitto 2
KG - Kirghizistan 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AW - Aruba 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 5.054
Città #
Santa Clara 547
Ashburn 308
Dublin 197
Singapore 157
Fairfield 152
Dong Ket 148
Chandler 141
Warsaw 111
San Jose 108
Hong Kong 104
Beijing 100
Cambridge 81
Milan 76
Seattle 72
Woodbridge 72
Wilmington 70
Seoul 62
Houston 59
Los Angeles 44
Munich 42
The Dalles 40
Council Bluffs 36
Ho Chi Minh City 36
New York 33
Florence 32
Rome 32
Princeton 31
Dallas 30
Mumbai 29
Altamura 24
Boston 24
Ann Arbor 23
Lauterbourg 23
Lawrence 23
Hanoi 22
Paris 22
Shanghai 22
Tokyo 21
Buffalo 20
Helsinki 20
Melbourne 19
Medford 14
Hefei 12
Kent 12
Turku 11
Boardman 10
Moscow 10
Abidjan 8
Toronto 8
West Jordan 8
Casablanca 7
Chennai 7
Chicago 7
Clifton 7
Figino 7
Montreal 7
Turin 7
São Paulo 6
Amsterdam 5
Atlanta 5
Barcelona 5
Bari 5
Naples 5
Phoenix 5
Poplar 5
San Diego 5
San Francisco 5
Stockholm 5
Tianjin 5
Amman 4
Belo Horizonte 4
Da Nang 4
Jakarta 4
Johannesburg 4
Querétaro 4
Romola 4
Tallinn 4
Brooklyn 3
Cagliari 3
Chongqing 3
Curitiba 3
Denver 3
Guangzhou 3
Guarulhos 3
London 3
Manchester 3
Redondo Beach 3
Rio de Janeiro 3
Verona 3
Washington 3
Baghdad 2
Baku 2
Bangkok 2
Bauru 2
Bern 2
Boca Raton 2
Bologna 2
Bremen 2
Brussels 2
Catania 2
Totale 3.507
Nome #
1,2,4-Benzothiadiazine-1,1-dioxide Derivatives as Ionotropic Glutamate Receptor Ligands: Synthesis and Structure–Activity Relationships 301
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 280
Characterization by flow cytometry of fluorescent, selective agonist probes of the A3 adenosine receptor 274
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 233
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino Derivatives As New Potent and Selective Human A3Adenosine Receptor Antagonists. Molecular Modeling Studies and Pharmacological Evaluation 232
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 230
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: Molecular modeling and pharmacological studies. 229
1,2,4-Triazolo[4,3-a]pyrazin-3-one as a new scaffold to develop potent adenosine receptor antagonists 224
A comprehensive strategy in the development of a cyclodextrin-modified microemulsion electrokinetic chromatographic method for the assay of diclofenac and its impurities: Mixture-process variable experiments and quality by design 221
1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure–affinity relationships and molecular modeling studies 212
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 191
Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation 175
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A1 and A2A adenosine receptors. Molecular modeling and pharmacological studies 175
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists. 172
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor 162
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: Synthesis, structure–affinity relationships and molecular modeling studies 157
2-Hydroxy-1,2,4-benzothiadiazin-1,1-dioxide derivatives as new antagonists of ionotropic glutamate receptors 149
Fluorescent ligands for adenosine receptors 146
2-Arylimidazo[1,2-a]pyrazin-8-amino derivatives as high-affinity fluorescent human A3 adenosine receptor antagonists with potential neuroprotective properties 142
New 5-heteroaryl-pyrazolo[4,3-d]pyrimidin-7-amines as dual human adenosine A1 and A2A receptor antagonists. 141
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives, new potent and selective human A3 adenosine receptor antagonists endowed with protective effect against oxaliplatin-induced apoptosis in rat astrocyte cell cultures 140
Imidazo[1,2-a]pyrazine core for the design of new adenosine receptor antagonist: optimization of A3 affinity and structural exploration to target the A2A subtype 132
Arilpirazolo[4,3-d]pirimidin-7-ammino derivati quali nuovi antagonisti potenti e selettivi del recettore umano A3 dell’adenosina 129
Quality by Design and Mixture-Process Variable approach in the development of a cyclodextrin-MEEKC method for the assay of diclofenac and its impurities 124
Structural investigations on 2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new human adenosine receptor antagonists. 121
Exploring the effect of 2- and 5-substituents on the pyrazolo[4,3-d]pyrimidin-7-amino derivatives to obtain human adenosine receptor antagonists 111
Thiazolo[5,4-d]pyrimidin-7-amino derivatives as new human A2A adenosine receptor antagonists 105
null 90
Synthesis and Pharmacological evaluation of some new 8-substitute-7-trifluoromethyl-4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates as AMPA/Kainate receptor antagonists 87
Totale 5.085
Categoria #
all - tutte 14.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022162 0 0 28 11 6 7 4 9 9 6 23 59
2022/2023553 48 98 34 33 47 90 78 48 51 2 13 11
2023/2024247 8 15 26 5 11 111 4 28 6 10 15 8
2024/20251.439 39 158 78 183 442 218 32 51 46 49 88 55
2025/20261.526 197 198 102 172 144 55 158 57 110 89 31 213
2026/2027171 44 39 88 0 0 0 0 0 0 0 0 0
Totale 5.085